David Douda

Title: David Douda: Innovator in Antibody Constructs

Introduction

David Douda is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of antibody constructs for cancer treatment. His innovative work has the potential to improve therapeutic options for patients battling cancer.

Latest Patents

David Douda holds a patent for "Multivalent and bispecific antibody constructs and methods of use thereof." This patent describes multivalent, such as trivalent, and bispecific antibody constructs that can bind to an antigen on a cytotoxic effector cell and a tumor-associated antigen (TAA) on a tumor cell. The patent also covers pharmaceutical compositions that include these antibody constructs and methods for their preparation and use, particularly in cancer treatment. He has 1 patent to his name.

Career Highlights

David Douda is currently associated with Zymeworks BC Inc., where he continues to advance his research and development efforts. His work at Zymeworks focuses on innovative solutions in the field of antibody engineering, contributing to the company's mission of improving patient outcomes through cutting-edge therapies.

Collaborations

David collaborates with talented professionals in his field, including Nicole Afacan and Chayne L Piscitelli. These collaborations enhance the research environment and foster innovation within the company.

Conclusion

David Douda is a key figure in the development of novel antibody constructs aimed at treating cancer. His contributions to biotechnology and his ongoing work at Zymeworks BC Inc. highlight his commitment to advancing medical science.